nach oben

Pediatric Nephrology

Erschienen in:

22.04.2021 | Educational Review

The pressure’s on: understanding neurocognitive and psychological associations with pediatric hypertension to inform comprehensive care

verfasst von: Anne E. Dawson, Mahmoud Kallash, John D. Spencer, Camille S. Wilson

Erschienen in: Pediatric Nephrology | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

The prevalence of hypertension is increasing in pediatric populations. While clinical data and practice guidelines identify the impact of hypertension on organ dysfunction and emphasize the importance for end-organ damage screening, the bidirectional effects of pediatric hypertension on neurocognitive and psychological outcomes are understudied. The objective of this review is to highlight the association between hypertension and cognition, attention, learning, and mental health in children and adolescents. In doing so, this review provides a framework and toolkit to integrate neuropsychology and psychology into the screening and management stages of pediatric hypertension. By recognizing the effects of hypertension on cognition, behavior, and mental health, screenings and interventions can be implemented to proactively and comprehensively improve the health outcomes for children with blood pressure concerns.

Tran CL, Ehrmann BJ, Messer KL, Herreshoff E et al (2012) Recent trends in healthcare utilization among children and adolescents with hypertension in the united states. Hypertension 60:296–302

Bell CS, Samuel JP, Samuels JA (2019) Prevalence of Hypertension in Children: Applying the New American Academy of Pediatrics Clinical Practice Guideline. Hypertension 73:148–152CrossRefPubMed

Guzman-Limon M, Samuels J (2019) Pediatric Hypertension: Diagnosis, Evaluation, and Treatment. Pediatr Clin N Am 66:45–57. https://doi.org/10.1016/j.pcl.2018.09.001CrossRef

Weaver DJ (2019) Pediatric hypertension: Review of updated guidelines. Pediatr Rev 40:354–358. https://doi.org/10.1542/pir.2018-0014CrossRefPubMed

Lubrano R, Travasso E, Raggi C, Guido G, Masciangelo R, Elli M (2009) Blood pressure load, proteinuria and renal function in pre-hypertensive children. Pediatr Nephrol 24:823–831. https://doi.org/10.1007/s00467-008-1077-6CrossRefPubMed

Adams HR, Szilagyi PG, Gebhardt L, Lande MB (2010) Learning and attention problems among children with pediatric primary hypertension. Pediatrics 126:e1425–e1429. https://doi.org/10.1542/peds.2010-1899CrossRefPubMed

Foster BJ, Ali H, Mamber S, Polomeno RC, MacKie AS (2009) Prevalence and severity of hypertensive retinopathy in children. Clin Pediatr (Phila) 48:926–930. https://doi.org/10.1177/0009922809339385CrossRef

Williams KM, Shah AN, Morrison D, Sinha MD (2013) Hypertensive retinopathy in severely hypertensive children: Demographic, clinical, and ophthalmoscopic findings from a 30-year British cohort. J Pediatr Ophthalmol Strabismus 50:222–228CrossRefPubMed

Daniels SR, Lipman MJ, Burke MJ, Loggie JMH (1991) The prevalence of retinal vascular abnormalities in children and adolescents with essential hypertension. Am J Ophthalmol 111:205–208. https://doi.org/10.1016/S0002-9394(14)72260-3CrossRefPubMed

10.

Cha SD, Patel HP, Hains DS, Mahan JD (2012) The Effects of Hypertension on Cognitive Function in Children and Adolescents. Int J Pediatr 2012:891094. https://doi.org/10.1155/2012/891094CrossRefPubMedPubMedCentral

11.

Kupferman JC, Lande MB, Adams HR, Pavlakis SG (2013) Primary hypertension and neurocognitive and executive functioning in school-age children. Pediatr Nephrol 28:401–408. https://doi.org/10.1007/s00467-012-2215-8CrossRefPubMed

12.

Lande MB, Kupferman JC (2019) Blood pressure and cognitive function in children and adolescents. Hypertension 73:532–540CrossRefPubMed

13.

Sharma M, Kupferman JC, Brosgol Y, Paterno K et al (2010) The effects of hypertension on the paediatric brain: A justifiable concern. Lancet Neurol 9:933–940. https://doi.org/10.1016/S1474-4422(10)70167-8

14.

Tyner E, Oropeza M, Figueroa J, Peña ICD (2019) Childhood Hypertension and Effects on Cognitive Functions: Mechanisms and Future Perspectives. CNS Neurol Disord Drug Targets 18:677–686CrossRefPubMed

15.

Urbina EM, Lande MB, Hooper SR, Daniels SR (2018) Target Organ Abnormalities in Pediatric Hypertension. J Pediatr 202:14–22. https://doi.org/10.1016/j.jpeds.2018.07.026CrossRefPubMed

16.

Vasilevska-Ristovska J, Hudes SZ, Naguleswaran K, Langlois V, Matsuda-Abedini M, Parekh RS (2018) Pediatric Hypertension: Impact on the Heart, Brain, Kidney, and Retina. Curr Cardiovasc Risk Rep 12:14. https://doi.org/10.1007/s12170-018-0577-6CrossRef

17.

Waldstein SR (1995) Hypertension and neuropsychological function: A lifespan perspective. Exp Aging Res 21:321–352CrossRefPubMed

18.

Genik LM, Yen J, McMurtry CM (2015) Historical analysis in pediatric psychology: The influence of societal and professional conditions on two early pediatric psychology articles and the field’s subsequent development. J Pediatr Psychol 40:167–174CrossRefPubMed

19.

Baron IS (2018) Neuropsychological Evaluation of Children: Domains, Methods, & Case Studies, 2nd edn. Oxford University Press, Oxford

20.

Flynn JT, Falkner BE (2017) New clinical practice guideline for the management of high blood pressure in children and adolescents. Hypertension 70:683–686CrossRefPubMed

21.

Walker KA, Power MC, Gottesman RF (2017) Defining the relationship between hypertension, cognitive decline, and dementia: A review. Curr Hypertens Rep 19:24. https://doi.org/10.1007/s11906-017-0724-3CrossRefPubMedPubMedCentral

22.

Suhr JA, Stewart JC, France CR (2004) The relationship between blood pressure and cognitive performance in the Third National Health and Nutrition Examination Survey (NHANES III). Psychosom Med 66:291–297PubMed

23.

Blanco PJ, Müller LO, Spence JD (2017) Blood pressure gradients in cerebral arteries: A clue to pathogenesis of cerebral small vessel disease. Stroke Vasc Neurol 2:108–117. https://doi.org/10.1136/svn-2017-000087CrossRefPubMedPubMedCentral

24.

Wong LJ, Kupferman JC, Prohovnik I, Kirkham FJ et al (2011) Hypertension impairs vascular reactivity in the pediatric brain. Stroke 42:1834–1838

25.

Litwin M (2018) Why should we screen for arterial hypertension in children and adolescents? Pediatr Nephrol 33:83–92. https://doi.org/10.1007/s00467-017-3739-8CrossRefPubMed

26.

Curcio S, Garcia-Espinosa V, Castro JM, Peluso G et al (2017) High blood pressure states in children, adolescents, and young adults associate accelerated vascular aging, with a higher impact in females’ arterial properties. Pediatr Cardiol 38:840–852CrossRefPubMed

27.

Settakis G, Páll D, Molnár C, Bereczki D, Csiba L, Fülesdi B (2003) Cerebrovascular reactivity in hypertensive and healthy adolescents: TCD with vasodilatory challenge. J Neuroimaging 13:106–112. https://doi.org/10.1177/1051228403251265CrossRefPubMed

28.

Páll D, Lengyel S, Komonyi É, Molnár C et al (2011) Impaired cerebral vasoreactivity in white coat hypertensive adolescents. Eur J Neurol 18:584–589. https://doi.org/10.1111/j.1468-1331.2010.03209.xCrossRefPubMed

29.

Iadecola C, Yaffe K, Biller J, Bratzke LC et al (2016) Impact of Hypertension on Cognitive Function: A Scientific Statement from the American Heart Association. Hypertension 68:e67–e94. https://doi.org/10.1161/HYP.0000000000000053CrossRefPubMed

30.

Meissner A (2016) Hypertension and the brain: A risk factor for more than heart disease. Cerebrovasc Dis 42:255–262. https://doi.org/10.1159/000446082CrossRefPubMed

31.

Center on the Developing Child at Harvard University (2011) Building the Brain’s “Air Traffic Control” System: How Early Experiences Shape the Development of Executive Function: Working Paper No. 11. http://www.developingchild.harvard.edu

32.

Diamond A, Ling DS (2016) Conclusions about interventions, programs, and approaches for improving executive functions that appear justified and those that, despite much hype, do not. Dev Cogn Neurosci 18:34–48. https://doi.org/10.1016/j.dcn.2015.11.005CrossRefPubMed

33.

Moffitt TE, Arseneault L, Belsky D, Dickson N et al (2011) A gradient of childhood self-control predicts health, wealth, and public safety. Proc Natl Acad Sci U S A 108:2693–2698. https://doi.org/10.1073/pnas.1010076108CrossRefPubMedPubMedCentral

34.

Noble KG, Norman MF, Farah MJ (2005) Neurocognitive correlates of socioeconomic status in kindergarten children. Dev Sci 8:74–87. https://doi.org/10.1111/j.1467-7687.2005.00394.xCrossRefPubMed

35.

Lande MB, Kaczorowski JM, Auinger P, Schwartz GJ, Weitzman M (2003) Elevated blood pressure and decreased cognitive function among school-age children and adolescents in the United States. J Pediatr 143:720–724. https://doi.org/10.1067/S0022-3476(03)00412-8CrossRefPubMed

36.

Lande MB, Gerson AC, Hooper SR, Cox C et al (2011) Casual blood pressure and neurocognitive function in children with chronic kidney disease: A report of the children with chronic kidney disease cohort study. Clin J Am Soc Nephrol 6:1831–1837. https://doi.org/10.2215/CJN.00810111CrossRefPubMedPubMedCentral

37.

Johnson RJ, Gerson AC, Harshman LA, Matheson MB et al (2020) A longitudinal examination of parent-reported emotional-behavioral functioning of children with mild to moderate chronic kidney disease. Pediatr Nephrol 35:1287–1295. https://doi.org/10.1007/s00467-020-04511-9CrossRefPubMedPubMedCentral

38.

Lande MB, Mendley SR, Matheson MB, Shinnar S et al (2016) Association of blood pressure variability and neurocognition in children with chronic kidney disease. Pediatr Nephrol 31:2137–2144CrossRefPubMedPubMedCentral

39.

Lande MR, Batisky DL, Kupferman JC, Samuels J et al (2017) Neurocognitive function in children with primary hypertension. J Pediatr 180:148–155CrossRefPubMed

40.

Ruebner RL, Laney N, Kim JY, Hartung EA et al (2016) Neurocognitive dysfunction in children, adolescents, and young adults with CKD. Am J Kidney Dis 67:567–575. https://doi.org/10.1053/j.ajkd.2015.08.025CrossRefPubMed

41.

Harshman LA, Hooper SR (2020) The brain in pediatric chronic kidney disease–the intersection of cognition, neuroimaging, and clinical biomarkers. Pediatr Nephrol 35:2221–2229. https://doi.org/10.1007/s00467-019-04417-1CrossRefPubMedPubMedCentral

42.

Harshman LA, Kogon AJ, Matheson MB, Johnson RJ et al (2020) Bicarbonate, blood pressure, and executive function in pediatric CKD—is there a link? Pediatr Nephrol 35:1323–1330. https://doi.org/10.1007/s00467-020-04507-5CrossRefPubMedPubMedCentral

43.

Hooper SR (2017) Risk factors for neurocognitive functioning in children with autosomal recessive polycystic kidney disease. Front Pediatr 5:107. https://doi.org/10.3389/fped.2017.00107CrossRefPubMedPubMedCentral

44.

Hooper SR, Gerson AC, Johnson RJ, Mendley SR et al (2016) Neurocognitive, social-behavioral, and adaptive functioning in preschool children with mild to moderate kidney disease. J Dev Behav Pediatr 37:231–238CrossRefPubMedPubMedCentral

45.

Kupferman JC, Batisky DL, Samuels J, Adams HR et al (2018) Ambulatory blood pressure monitoring and neurocognitive function in children with primary hypertension. Pediatr Nephrol 33:1765–1771CrossRefPubMedPubMedCentral

46.

Matsuda-Abedini M, Fitzpatrick K, Harrell WR, Gipson DS et al (2018) Brain abnormalities in children and adolescents with chronic kidney disease. Pediatr Res 84:387–392. https://doi.org/10.1038/s41390-018-0037-5CrossRefPubMedPubMedCentral

47.

Filley CM, Fields RD (2016) White matter and cognition: Making the connection. J Neurophysiol 116:2093–2104. https://doi.org/10.1152/jn.00221.2016CrossRefPubMedPubMedCentral

48.

Peer M, Nitzan M, Bick AS, Levin N, Arzy S (2017) Evidence for functional networks within the human brain’s white matter. J Neurosci 37:6394–6407CrossRefPubMedPubMedCentral

49.

Elias PK, Elias MF, Robbins MA, Budge MM (2004) Blood pressure-related cognitive decline: Does age make a difference? Hypertension 44:631–636. https://doi.org/10.1161/01.HYP.0000145858.07252.99CrossRefPubMed

50.

Crichton GE, Elias MF, Dore GA, Torres RV, Robbins MA (2014) Measurement-to-measurement blood pressure variability is related to cognitive performance: The maine syracuse study. Hypertension 64:1094–1101. https://doi.org/10.1161/HYPERTENSIONAHA.114.04282CrossRefPubMed

51.

Waldstein SR, Jennings JR, Ryan CM, Muldoon MF et al (1996) Hypertension and neuropsychological performance in men: Interactive effects of age. Health Psychol 15:102–109. https://doi.org/10.1037/0278-6133.15.2.102CrossRefPubMed

52.

Yaffe K, Vittinghoff E, Pletcher MJ, Hoang TD et al (2014) Early adult to midlife cardiovascular risk factors and cognitive function. Circulation 129:1560–1567CrossRefPubMedPubMedCentral

53.

Rovio SP, Pahkala K, Nevalainen J, Juonala M et al (2017) Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance: The Young Finns Study. J Am Coll Cardiol 69:2279–2289CrossRefPubMed

54.

Baluarte JH (2017) Neurological Complications of Renal Disease. Semin Pediatr Neurol 24:25–32. https://doi.org/10.1016/j.spen.2016.12.004CrossRefPubMed

55.

Mendizabal B, Urbina EM, Becker R, Daniels SR et al (2018) SHIP-AHOY (Study of high blood pressure in pediatrics: Adult hypertension onset in youth): Rationale, design, and methods. Hypertension 72:625–631CrossRefPubMed

56.

Waldstein S, Snow J, Muldoon M, Katzel L (2001) Neuropsychological consequences of cardiovascular disease. In: Tarter RE, Butters M, Beers S (eds) Medical Neuropsychology, 2nd edn. Kluwer Academic/Plenum, Dordrecht, pp 51–83

57.

Lande MB, Adams H, Falkner B, Waldstein SR et al (2009) Parental Assessments of Internalizing and Externalizing Behavior and Executive Function in Children with Primary Hypertension. J Pediatr 154:207–212. https://doi.org/10.1016/j.jpeds.2008.08.017CrossRefPubMed

58.

Grisaru S, Yue MW, Mah JC, Hamiwka LA (2013) Ambulatory blood pressure monitoring in a cohort of children referred with suspected hypertension: Characteristics of children with and without attention deficit hyperactivity disorder. Int J Hypertens 2013:419208. https://doi.org/10.1155/2013/419208CrossRefPubMedPubMedCentral

59.

American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders (DSM-5), 5th ed. American Psychiatric Publishing, Washington DC

60.

Blanchflower DG, Oswald AJ (2008) Hypertension and happiness across nations. J Health Econ 27:218–233CrossRefPubMed

61.

Stein DJ, Aguilar-Gaxiola S, Alonso J, Bruffaerts R et al (2014) Associations between mental disorders and subsequent onset of hypertension. Gen Hosp Psychiatry 36:142–149. https://doi.org/10.1016/j.genhosppsych.2013.11.002CrossRefPubMed

62.

Tevie J, Shaya FT (2015) Association between mental health and comorbid obesity and hypertension among children and adolescents in the US. Eur Child Adolesc Psychiatry 24:497–502. https://doi.org/10.1007/s00787-014-0598-8CrossRefPubMed

63.

Bieber AK, Pehrson LJ, Vento S, Malaga-Dieguez L, Spruill TM, Trachtman H (2020) The Psychosocial Impact of a Diagnosis of Hypertension in Pediatric Patients. Kidney Int Rep 5:228–230. https://doi.org/10.1016/j.ekir.2019.11.006CrossRefPubMed

64.

Qorbani M, Kelishadi R, Taheri E, Motlagh ME et al (2014) Association between psychosocial distress with cardio metabolic risk factors and liver enzymes in a nationally-representative sample of Iranian children and adolescents: The CASPIAN-III study. J Diabetes Metab Disord 13:44. https://doi.org/10.1186/2251-6581-13-44CrossRefPubMedPubMedCentral

65.

Kretchy IA, Owusu-Daaku FT, Danquah SA (2014) Mental health in hypertension: Assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence. Int J Ment Heal Syst 8:4–9. https://doi.org/10.1186/1752-4458-8-25CrossRef

66.

Parks J, Pollack D (eds) (2005) Integrating Behavioral Health and Primary Care Services: Opportunities and Challenges for State Mental Health Authorities. Eleventh in a Series of Technical Reports. http://www.nasmhpd.org

67.

Davidson K, Jonas BS, Dixon KE, Markovitz JH (2000) Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Arch Intern Med 160:1495–1500CrossRefPubMed

68.

Medrano L, Amatya K, Vizthum D, Fadrowski JJ, Brady TM (2018) Association of mood disorders with cardiovascular disease risk factors in overweight and obese youth with elevated blood pressure. J Clin Hypertens 20:1268–1275. https://doi.org/10.1111/jch.13348CrossRef

69.

Lambert E, Dawood T, Straznicky N, Sari C et al (2010) Association between the sympathetic firing pattern and anxiety level in patients with metabolic syndrome and elevated blood pressure. J Hypertens 28:543–550CrossRefPubMed

70.

Jhalani J, Goyal T, Clemow L, Schwartz JE, Pickering TG, Gerin W (2005) Anxiety and outcome expectations predict the white-coat effect. Blood Press Monit 10:317–319. https://doi.org/10.1097/00126097-200512000-00006CrossRefPubMed

71.

Carels RA, Sherwood A, Blumenthal JA (1998) High Anxiety and White Coat Hypertension. JAMA J Am Med Assoc 279:197–198CrossRef

72.

Ogedegbe G, Pickering TG, Clemow L, Chaplin W et al (2008) The Misdiagnosis of Hypertension: the role of patient anxiety. Arch Intern Med 168:2459. https://doi.org/10.1001/archinte.168.22.2459CrossRefPubMedPubMedCentral

73.

Krause I, Cleper R, Kovalski Y, Sinai L, Davidovits M (2009) Changes in behavior as an early symptom of renovascular hypertension in children. Pediatr Nephrol 24:2271–2274. https://doi.org/10.1007/s00467-009-1205-yCrossRefPubMed

74.

Croix B, Feig DI (2006) Childhood hypertension is not a silent disease. Pediatr Nephrol 21:527–532. https://doi.org/10.1007/s00467-006-0013-xCrossRefPubMed

75.

Barkmann C, Braehler E, Schulte-Markwort M, Richterich A (2011) Chronic somatic complaints in adolescents: Prevalence, predictive validity of the parent reports, and associations with social class, health status, and psychosocial distress. Soc Psychiatry Psychiatr Epidemiol 46:1003–1011. https://doi.org/10.1007/s00127-010-0273-4CrossRefPubMed

76.

Enright PL, Goodwin JL, Sherrill DL, Quan JR, Quan SF (2003) Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and hispanic children: The Tucson children’s assessment of sleep apnea study. Arch Pediatr Adolesc Med 157:901–904. https://doi.org/10.1001/archpedi.157.9.901CrossRefPubMed

77.

Marcus CL, Greene MG, Carroll JL (1998) Blood pressure in children with obstructive sleep apnea. Pneumologie 52:469

78.

Lande MB, Hooper SR, Batisky DL, Kupferman JC et al (2015) Sleep disordered breathing as measured by SRBD-PSQ and neurocognition in children with hypertension. Am J Hypertens 28:552–558. https://doi.org/10.1093/ajh/hpu180CrossRefPubMed

79.

Madaeva I, Berdina O, Polyakov V, Kolesnikov S (2016) Obstructive sleep apnea and hypertension in adolescents: Effect on neurobehavioral and cognitive functioning. Can Respir J 2016:3950914. https://doi.org/10.1155/2016/3950914CrossRefPubMedPubMedCentral

80.

Oliveros E, Patel H, Kyung S, Fugar S et al (2020) Hypertension in older adults: Assessment, management, and challenges. Clin Cardiol 43:99–107. https://doi.org/10.1002/clc.23303CrossRefPubMed

81.

Yan LL, Liu K, Matthews KA, Daviglus ML, Ferguson TF, Kiefe CI (2003) Psychosocial factors and risk of hypertension: The coronary artery risk development in young adults (CARDIA) study. JAMA 290:2138–2146CrossRefPubMed

82.

Stein DJ, Scott K, Abad JMH, Aguilar-Gaxiola S et al (2010) Early childhood adversity and later hypertension: Data from the World Mental Health Survey. Ann Clin Psychiatry 22:19–28PubMedPubMedCentral

83.

Gooding HC, Milliren CE, Austin SB, Sheridan MA, McLaughlin KA (2016) Child Abuse, Resting Blood Pressure, and Blood Pressure Reactivity to Psychosocial Stress. J Pediatr Psychol 41:5–14CrossRefPubMed

84.

Ewart CK (2004) Social environments, agnostic stress, and elevated blood pressure in urban youth. In: Portman RJ, Sorof JM, Ingelfinger JR (eds) Pediatric Hypertension. Humana Press, New York, pp 335–349

85.

Min J, Griffis HM, Tam V, Meyers KE, Natarajan SS (2020) Association of neighborhood-level social determinants and food environments with pediatric hypertension care. Health Place 65:102383. https://doi.org/10.1016/j.healthplace.2020.102383CrossRefPubMed

86.

Beatty Moody DL, Chang YF, Pantesco EJ, Darden TM et al (2019) Everyday discrimination prospectively predicts blood pressure across 10 years in racially/ethnically diverse midlife women: Study of women’s health across the nation. Ann Behav Med 53:608–620. https://doi.org/10.1093/abm/kay069CrossRef

87.

Samuels JA, Franco K, Wan F, Sorof JM (2006) Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: A double-blind, randomized, cross-over trial. Pediatr Nephrol 21:92–95. https://doi.org/10.1007/s00467-005-2051-1CrossRefPubMed

88.

Wolraich ML, Hagan JF, Allan C, Chan E (2015) Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents. Dev Pediatr 144:54–54. https://doi.org/10.5005/jp/books/12480_13CrossRef

89.

Evans SW, Owens JS, Wymbs BT, Ray AR (2018) Evidence-Based Psychosocial Treatments for Children and Adolescents With Attention Deficit/Hyperactivity Disorder. J Clin Child Adolesc Psychol 47:157–198. https://doi.org/10.1080/15374416.2017.1390757CrossRefPubMed

90.

Lande MB, Adams H, Falkner B, Waldstein SR et al (2010) Parental Assessment of Executive Function and Internalizing and Externalizing Behavior in Primary Hypertension after Anti-Hypertensive Therapy. J Pediatr 157:114–119. https://doi.org/10.1016/j.jpeds.2009.12.053CrossRefPubMedPubMedCentral

91.

Haws R, Joseph M, Adelman R (2008) Two cases of pheochromocytoma presenting with ADHD (attention deficit hyperactivity disorder)-like symptoms. Pediatr Nephrol 23:473–475. https://doi.org/10.1007/s00467-007-0625-9CrossRefPubMed

92.

Gallibois CM, Jawa NA, Noone DG (2017) Hypertension in pediatric patients with chronic kidney disease: Management challenges. Int J Nephrol Renov Dis 10:205–213CrossRef

93.

Miyashita Y, Flynn JT, Hanevold CD (2017) Diagnosis and management of white-coat hypertension in children and adolescents: A Midwest Pediatric Nephrology Consortium study. J Clin Hypertens 19:884–889. https://doi.org/10.1111/jch.13006CrossRef

94.

Jurko A, Minarik M, Jurko T, Tonhajzerova I (2016) White coat hypertension in pediatrics. Ital J Pediatr 42:4. https://doi.org/10.1186/s13052-016-0213-3CrossRefPubMedPubMedCentral

95.

Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N (2005) White-coat and masked hypertension in children: Association with target-organ damage. Pediatr Nephrol 20:1151–1155. https://doi.org/10.1007/s00467-005-1979-5CrossRefPubMed

96.

Falkner B (2018) The Childhood Role in Development of Primary Hypertension. Am J Hypertens 31:762–769. https://doi.org/10.1093/ajh/hpy058CrossRefPubMed

97.

Kavey REW, Kveselis DA, Atallah N, Smith FC (2007) White Coat Hypertension in Childhood: Evidence for End-Organ Effect. J Pediatr 150:491–497. https://doi.org/10.1016/j.jpeds.2007.01.033CrossRefPubMed

98.

Matsuoka S, Kawamura K, Honda M, Awazu M (2002) White coat effect and white coat hypertension in pediatric patients. Pediatr Nephrol 17:950–953. https://doi.org/10.1007/s00467-002-0990-3CrossRefPubMed

99.

Hanevold CD (2019) White Coat Hypertension in Children and Adolescents. Hypertension 73:24–30CrossRefPubMed

100.

Krmar RT (2019) White-coat hypertension from a paediatric perspective. Acta Paediatr Int J Paediatr 108:44–49. https://doi.org/10.1111/apa.14416CrossRef

101.

Muldoon MF, Nazzaro P, Sutton-Tyrrell K, Manuck SB (2000) White-coat hypertension and carotid artery atherosclerosis: A matching study. Arch Intern Med 160:1507–1512. https://doi.org/10.1001/archinte.160.10.1507CrossRefPubMed

102.

Cobos B, Haskard-Zolnierek K, Howard K (2015) White coat hypertension: Improving the patient–health care practitioner relationship. Psychol Res Behav Manag 8:133–141. https://doi.org/10.2147/PRBM.S61192CrossRefPubMedPubMedCentral

103.

Lurbe E, Torro I, Alvarez V, Nawrot T et al (2005) Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension 45:493–498CrossRefPubMed

104.

Lande MB, Batisky DL, Kupferman JC, SAmuels J et al (2018) Neurocognitive Function in Children with Primary Hypertension after Initiation of Antihypertensive Therapy. J Pediatr 195:85–94.e1. https://doi.org/10.1016/j.jpeds.2017.12.013CrossRefPubMedPubMedCentral

105.

Hardy KK, Olson K, Cox SM, Kennedy T, Walsh KS (2017) A prevention based model of neuropsychological assessment for children with medical illness. J Pediatr Psychol 42:815–822CrossRefPubMedPubMedCentral

106.

Castellanos I, Kronenberger WG, Pisoni DB (2018) Questionnaire-based assessment of executive functioning: Psychometrics. Appl Neuropsychol 7:93–109CrossRef

107.

Bard DE, Wolraich M, Neas B, Doffing M, Beck L (2013) The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic parent rating scale in a community population. J Dev Behav Pediatr 34:72–82CrossRefPubMed

108.

Faulstich ME, Carey MP, Ruggiero L, Enyart P, Gresham F (1986) Assessment of depression in childhood and adolescence: An evaluation of the Center for Epidemiological Studies Depression Scale for Children (CES-DC). Am J Psychiatry 143:1024–1027CrossRefPubMed

109.

Birmaher B, Brent DA, Chiappetta L, Bridge L, Monga S, Baugher M (1999) Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): A replication study. J Am Acad Child Adolesc Psychiatry 38:1230–1236CrossRefPubMed

110.

Bruni O, Ottaviano S, Guidetti V, Romoli M et al (1996) The Sleep Disturbance Scale for Children (SDSC) construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. J Sleep Res 5:251–261. https://doi.org/10.1111/j.1365-2869.1996.00251.xCrossRefPubMed

111.

Kiessling SG, McClanahan KK, Omar HA (2008) Obesity, hypertension, and mental health evaluation in adolescents: A comprehensive approach. Int J Adolesc Med Health 20:5–15. https://doi.org/10.1515/IJAMH.2008.20.1.5CrossRefPubMed

112.

Adams HR, Szilagyi PG, Gebhardt L, Lande MB (2010) Learning and attention problems among chidlren with pediatric primary hypertension. Pediatrics 126:e1425–e1429. https://doi.org/10.1016/j.physbeh.2017.03.040CrossRefPubMed

Titel: The pressure’s on: understanding neurocognitive and psychological associations with pediatric hypertension to inform comprehensive care
verfasst von: Anne E. Dawson
Mahmoud Kallash
John D. Spencer
Camille S. Wilson
Publikationsdatum: 22.04.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Pediatric Nephrology / Ausgabe 12/2021
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-021-05077-w

Neu im Fachgebiet Pädiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

16.05.2024 Arterielle Hypertonie in der Pädiatrie Nachrichten

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

The pressure’s on: understanding neurocognitive and psychological associations with pediatric hypertension to inform comprehensive care

Abstract

Neu im Fachgebiet Pädiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update Pädiatrie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2021

Urine collection methods for infants under 3 months of age in clinical practice

Solving an unusual case of acute kidney injury: Answers

Correction to: An infant with hyperechoic cystic kidneys and congenital diaphragmatic hernia: Answers

Pseudo-Bartter syndrome and staghorn calculi in an infant with chronic diarrhea: Answers

Omentectomy reduces the need for peritoneal dialysis catheter revision in children: a study from the Pediatric Nephrology Research Consortium

Diagnostic accuracy of an interdisciplinary tertiary center evaluation in children referred for suspected congenital anomalies of the kidney and urinary tract on fetal ultrasound - a retrospective outcome analysis

Neu im Fachgebiet Pädiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update Pädiatrie